CATAPULT THERAPEUTICS

Catapult Therapeutics is a privately held Dutch biotech company developing CAP-100 – an innovative first-in-class humanized anti-CCR7 antibody. The chemokine receptor CCR7 is over-expressed in many cancers, and high CCR7 expression is associated with poor prognosis and short survival in hematological and solid malignancies. Preclinical studies have shown that the anti-CCR7 antibody can prolong survival and inhibit cancer cell migration in multiple animal models of B-cell and T-cell lymphomas.

#SimilarOrganizations #People #Website #More

CATAPULT THERAPEUTICS

Industry:

Biotechnology

Address:

Lelystad, Flevoland, The Netherlands

Country:

The Netherlands

Website Url:

http://www.catapult-therapeutics.com

Status:

Active

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics